CN Patent

CN116745292A — 经取代的吡啶并三嗪化合物及其用途

Assigned to Gilead Sciences Inc · Expires 2023-09-12 · 3y expired

What this patent protects

本公开整体涉及某些三环化合物、包含所述化合物的药物组合物以及制备所述化合物和药物组合物的方法。本公开的化合物可用于治疗或预防人类免疫缺陷病毒(HIV)感染。

USPTO Abstract

本公开整体涉及某些三环化合物、包含所述化合物的药物组合物以及制备所述化合物和药物组合物的方法。本公开的化合物可用于治疗或预防人类免疫缺陷病毒(HIV)感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN116745292A
Jurisdiction
CN
Classification
—
Expires
2023-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.